Martha’s Vineyard TimesScience and Scientists on the Vineyard: Genes at play with CRISPRMartha’s Vineyard TimesCRISPR-Cas9 as a tool for genetic editing has a history that goes back to a 2011 scientific conference at which microbiologist Emmanuelle Cha… Continue reading
|
‘Advances made in stem cell therapy in Asia far more than those made in US’
The Hindu Indigenously developed therapeutic modules for neuro development disorders like autism have demonstrated a higher rate of recovery and improvement among sufferers, Nandini Gokulchandran, a Mumbai-based researcher in the field of stem cell therapy … |
|
Evolving Education Initiative Keeps Nurses Up-to-Date on CAR T Cell Therapy Best Practices
Oncology Nurse Advisor DENVER — Use of a multidisciplinary education initiative effectively prepared nursing and clinical staff for the challenges of managing care and follow-up of patients undergoing chimeric antigen receptor T cell (CAR-T) therapy across multiple … |
|
Evolving Education Initiative Keeps Nurses Up-to-Date on CAR T Cell Therapy Best Practices
Oncology Nurse Advisor DENVER — Use of a multidisciplinary education initiative effectively prepared nursing and clinical staff for the challenges of managing care and follow-up of patients undergoing chimeric antigen receptor T cell (CAR-T) therapy across multiple … |
Shanghai Daily (subscription) |
Positive results from gene therapy for blood cancer
Shanghai Daily (subscription) DOCTORS are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level … |
Mesothelioma & Asbestos Awareness Center |
Hopes High for Mesothelioma Immunotherapy Treatment
Mesothelioma.net Blog (blog) But a phase II clinical trial being conducted in France has indicated that the use of immunotherapy has shown a dramatic slowdown in the speed with which mesothelioma grows after it has made its return. Researchers have found that at 12 weeks post … Things to Keep in Mind Before Joining a Clinical TrialMesothelioma & Asbestos Awareness Center (blog) |
|
AveXis and REGENXBIO Sign Licensing Agreement to Develop Therapies for ALS and Rett syndrome
ALS News Today AveXis will use REGENXBIO’s gene-delivery platform, NAV AAV9 vector, to help it develop therapies for rare, inherited and life-threatening neurological diseases. NAV AAV9 vector delivers a healthy gene, placed inside the shell of an adeno-associated … |
PR Newswire UK |
MilliporeSigma Wins Its First CRISPR Patent in Australia
Genetic Engineering & Biotechnology News MilliporeSigma, the life science business of Merck KGaA, said today it has been awarded its first patent for CRISPR technology—an Australian patent relating to the use of CRISPR in a genomic integration method for eukaryotic cells. The patent issued … MilliporeSigma Awarded its First CRISPR Patent by Australian …Canada NewsWire (press release) Guest Post: Crispr Craze and Crispr Cares | Practical EthicsPractical Ethics (blog) |